BioPharm International, August 2014 - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

BioPharm International, August 2014
Cover Story
Single-Domain Antibodies for Brain Targeting
By Aikaterini Lalatsa , Diana M. Leite
Single-domain antibodies are emerging as credible alternatives due to their target specificity, high affinity, and cost-effective recombinant production.
Featured Article
Optimizing Human Performance, Part II: A Road Worth Traveling
By Gerry McAuley
Part II of this three-part series presents a roadmap to human error prevention.
Peer-Reviewed Research
Environmental Responsibility in Chinese Biopharmaceutical Companies
By Li Wei , Yu Ruixiang
Corporate environmental responsibility (CER) is on the corporate and political agenda in China. This study determined the relevance of environmental aspects for biopharmaceutical companies in China and presents a new perspective that calls for an integration of CER into the business strategy as a source of competitive advantages.
Features
Ensuring the Safety, Quality, and Identity of Biopharmaceutical Raw Materials
By Cynthia Challener, PhD
Going beyond pharmacopeial requirements is essential for the quality and safety of raw materials.
Marrying Big Data with Personalized Medicine
By Jill E. Sackman, PhD , Michael Kuchenreuther
Data analytic strategies can help companies capitalize on personalized medicine.
Regulatory Beat
Changes and Challenges for Generic Drugs
By Jill Wechsler
FDA seeks high quality applications and products to facilitate approvals and reduce safety and supply problems.
Manufacturing Best Practices
Applying GMPs to the BioPharma Supply Chain
By Simon Chalk
Defining best biopharmaceutical practices is necessary to ensure the safety of the supply chain.
Perspectives on Outsourcing
Relationship-building at Top of Mind for Clients
By Eric Langer
Annual study shows technical expertise is not enough.
Disposables Advisor
Stirring the Mix of Single-Use Mixers
By Jerold Martin
Single-use products offer options and choices for biopharma mixing.
From the Editor
A Silver Milestone for Drug Development
By Rita Peters
Pharmaceutical Technology Europe marks 25 years of drug-development advances.
Products
Hybrid Purifer Enhances Efficiency
3M’s Emphaze AEX Hybrid Purifier combines polymers, fine fiber nonwovens, and membranes to create an all-synthetic clarifying product line.

ADVERTISEMENT

ADVERTISEMENT

Click here